HLA-DRB1 H13/H33 amino acid is associated with reduced tau and neurofibrillary tangles and to a lesser extent with reduced Amyloid-β or neuritic plaques, when testing their association with AD neuropathology and CSF biomarkers. This evidence concerns the gene MAPT and Alzheimer disease.